The Medicines and Healthcare products Regulatory Agency (MHRA) has announced the successful reclassification of Nasonex Allergy Control 0.05% Nasal Spray following a public consultation. The spray, which will soon be available over the counter in pharmacies, is used to treat symptoms of allergic rhinitis. 

The decision follows the POM to P reclassification granted to Maloff Protect last week. MHRA commented that is “committed to involving people in their healthcare, and to widen access to medicines for the benefit of public health when it is safe to do”.

We Recommend

Pharmacy professionals devise cuts strategy

Start engaging with today's challenges, Alphega members urged colleagues at a recent workshop

190 LloydsPharmacy stores to close

LloydsPharmacy has said it is to cease trading in approximately 190 of its stores in England and will do 'all it can' to...

Popular Features

Is the GPhC consultation preaching to the choir?

Is the GPhC consultation on responsibilities for patient safety an insult to non-pharmacistmanagers, or simply an extra ...

Combination feeding

Some parents may wish to feed their baby using a combination of breastfeeding and bottle feeding – using either expres...

Entrepreneurship

Entrepreneurial skills can be useful across all areas of a pharmacy business.